Icon

DYMISTA (nda202236)- (0.137MG/SPRAY;0.05MG/SPRAY)

AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE MYLAN SPECIALITY LP
0.137MG/SPRAY;0.05MG/SPRAY
Yes Yes
2026-Aug-24 Expired
None None
None No
DYMISTA contains an H1-receptor antagonist and a corticosteroid, and is indicated for the relief of symptoms of seasonal allergic rhinitis in adult and pediatric patients 6 years of age and older.
2 1 2
Total Other Developers 6
Drugs with Suitability No
0.137MG/SPRAY;0.05MG/SPRAY ** ** Down - 2
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** ******* ****** ******* ****** *************** *** *********** * ********* ***, *******, *******, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.